內地4月乘用車零售銷量按年增55.5% 按月增2.5%
中國乘用車市場信息聯席會公布數據顯示,受去年同期上海、吉林等地疫情影響,4月乘用車市場零售銷量163萬輛,按年增55.5%,按月增2.5%,為自2010年以來僅有的兩次按月正增長之一。
4月份,乘用車出口30萬輛,按年飆升2.27倍,按月增長3%。今年首四個月,出口108萬輛,按年增長1.15倍。新能源乘用車出口9.1萬輛,按年增長10.29倍,按月增長29.4%,佔乘用車出口的31%。
乘聯會指出,4月價格戰熱度逐漸消退,經銷商恐慌心態逐步穩定,消費者恢復理性消費,觀望情緒得以緩解,前期壓抑的需求有所釋放。展望5月車市,受去年同期銷量表現因供應鏈不穩定因素干擾,5月銷量按年或繼續呈現寬幅增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.